InvestorsHub Logo
Followers 31
Posts 6494
Boards Moderated 0
Alias Born 01/20/2016

Re: chrismiss_everyday post# 385422

Monday, 11/28/2022 7:35:30 AM

Monday, November 28, 2022 7:35:30 AM

Post# of 464899
Treatment caused death of patient in Biogen AD trial--this from an expert who studied cause of death---"It was a one-two punch,” Castellani says. “There’s zero doubt in my mind that this is a treatment-caused illness and death. If the patient hadn’t been on lecanemab she would be alive today.” (Castellani says his comments reflect personal views and were not reviewed or approved by Northwestern. The patient’s husband told Science he authorized Castellani to speak publicly about his wife’s case. Science agreed to withhold both names to protect the family’s privacy.)----so who will be the clear-cut winner at CTAD ???? Of course Anavex--our drug is effective and Safe !!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News